RecruitingNot ApplicableNCT06735833

MMA Embolization for Refractory Chronic Migraine

Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine

Sponsor

Cerenovus, Part of DePuy Synthes Products, Inc.

Enrollment

70 participants

Start Date

Apr 23, 2025

Study Type

INTERVENTIONAL

Conditions

Migraine Disorders

Summary

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Middle Meningeal Artery embolization for people with migraine disorders. The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMiddle Meningeal Artery embolization

Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system

Locations(9)

Barrow Neurological Institute at St. Joseph's Hospital

Phoenix, Arizona, United States

John Muir Physician Network Clin. Research Center

Walnut Creek, California, United States

Hartford Hospital

Hartford, Connecticut, United States

University of Buffalo Medical Center

Buffalo, New York, United States

Mount Sinai

New York, New York, United States

Stony Brook University Medical Center

Stony Brook, New York, United States

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

Semmes Murphey Foundation

Memphis, Tennessee, United States

West Virginia University

Morgantown, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06735833

Related Trials

MMA Embolization for Refractory Chronic Migraine

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(9)

Related Trials

Migraine Attack Pain Phase Prediction Study

Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

Mind Body Balance for Pediatric Migraine

Determining the Utility of a Behavioral Intervention in Chronic Migraine

Responding With Evidence and Access for Childhood Headaches